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ABSTRACT OF THESIS 
 
 
 
 
 
EFFECT OF LOWER BODY POSITIVE PRESSURE ON CARDIOVASCULAR 
RESPONSE AT VARIOUS DEGREES OF HEAD-UP TILT 
 
Various models of simulated weightlessness and resulting cardiovascular effects 
have been researched in the last 50 years of space exploration.  Examples of such models 
are the Alter-G (Alt-G) treadmill used for body unweighting and head-up-tilt  (HUT) model 
each providing similar cardiovascular effects, but differing in their stimulation of vestibular 
centers . Advantages of using the Alt-G include: use of lower body positive pressure (LBPP) 
to simulate hypogravity, it acts as a countermeasure to alleviate negative cardiovascular 
effects of standing and provides a constant vestibular stimulus. In addition, the Alt-G shorts 
themselves may be providing a certain degree of LBPP, acting as a compression garment. 
Therefore the purpose of this study was to determine the cardiovascular effects of Alt-G 
shorts and how effective they are as countermeasure to deconditioning effects of space 
flight. 
This study tested cardiovascular changes in 12 men and women at 0 and 80 degrees 
head-up-tilt (HUT0 / HUT80) with and without Alt-G shorts using 5-lead ECG, 10-lead 
impedance, heart rate, systolic and diastolic blood pressure measurements at finger and 
arm. The tilt-induced increase in mean heart rate (HR) was significantly smaller when 
subjects wore the Alt-G shorts. Shorts ended up reducing HR by 2.3 bpm in supine control 
and by 6.7 bpm at HUT80 (p<0.05). The tilt effect was also significant (HUT/control, vs. 
HUT80), 66.4 vs. 91.5 bpm with no shorts and 64.1 vs. 84.8 bpm with shorts (p<0.0005).  In 
addition, the tilt-induced decrease in systolic blood pressure (SBP) was significantly smaller 
when subjects wore the Alt-G shorts. Shorts helped maintain SBP when moving from 0 to 80 
degree tilt, avg. 6.6 vs. 10.8 mmHg (p<0.05) decrease in SBP for shorts vs. no shorts. The 
tilt effect (HUT0, vs. HUT80) was not significantly different (p>0.05. Other cardiovascular 
variables did not show any significant effect from shorts. 
In conclusion, this study was in line with results from other studies that used 
compression garments to determine cardiovascular effects of LBPP. 
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Chapter One 
 
Introduction 
 
Orthostatic hypotension (OH) and orthostatic intolerance (OI) are less serious, but 
more pervasive, manifestations of adrenergic failure, in the progression of autonomic 
disorders such as autonomic neuropathies, autonomic failure and multiple system atrophy 
(Denq et al., 1997). OI is a common problem in aging populations and it affects 
approximately 30% of short duration and 80% of long-duration astronauts post-flight 
(Stenger et al., 2011) due to cardiovascular de-conditioning (i.e., heart shrinkage, body 
dehydration and plasma volume reduction) occurring with microgravity.  
Therapeutic approaches to OI primarily consist of vasoconstrictor drugs, increasing blood 
volume and the use of compression garments due to the lower body positive pressure 
(LBPP) they create. The latter is the main topic of this study. 
Crile introduced LBPP with the antigravity suit (G suit) or medical anti-shock trousers 
in 1903. The principle of the G suit has been applied to the treatment of OI. The 
development of new materials allowed the fabrication of elastic suits that are able to apply 
even or gradient pressure. However, there is little systematic information about the effects of 
compression of various venous capacitance beds and their use as a significant counter-
measure for returning astronauts.  
The efficacy of compression of specific body compartments (calves, thighs, low 
abdomen, calves and thighs together, and all compartments combined) has been looked at 
by Denq (1997). The main finding was that compression garments significantly reduced the 
deficit in standing blood pressure (BP) if both legs and the abdomen are compressed or if 
the abdomen alone is compressed due to substantial amount of fluid in the human gut area. 
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Compression in the region of calves, thighs or combined calves and thighs did not show 
results as impressive as the abdomen data, nevertheless, in a study by Stenger et al.(2010), 
thigh-high, graded compression garments were found to be an effective counter-measure to 
mitigating the symptoms of OI. However, full-body compression suits, showed the most 
significant effect, as in a study by Platts et al.(2009), who compared NASA’s inflatable 
antigravity suit (AGS) and the Russian Federal Space Agency’s non-inflatable compression 
garment “Kentavr” (a.k.a. “Centaurus”). In all the studies above, compression garments 
prevented the symptoms of OI by decreasing venous pooling of the calves and thighs, 
thereby improving venous return and stroke volume (SV). Systolic blood pressures (SBP) 
and total peripheral resistances (TPR) were higher with garments, while heart rates (HR) 
were lower.  
The present study focuses on a garment that compresses the abdominal and upper 
legs with the use of Alt-G shorts. The Alt-G shorts are an integral part of the Alt-G treadmill, 
which uses LBPP to reduce body weight and therefore simulate reduced gravity.  In the Alt-
G, the subject, wearing special Alt-G shorts is sealed at the waist inside the LBPP enclosure 
and positive air pressure is applied to the subject’s lower body while they stand, walk or run 
on an enclosed treadmill.  
The selection of Alt-G shorts as a compression garment in this study was based on 
several studies (Evans JM et al., 2010; Kostas V. et al. 2011 – in progress), which 
compared the cardiovascular effects between  Alt-G and  head up tilt (HUT) models of 
reduced gravity. Specifically, data obtained at four body weights (BW) produced by the Alt-G 
were compared to data acquired from four degrees of HUT (Moon stand=20% BW [AG] vs 
10° HUT), (Mars stand=40% BW [AG] vs. 20° HUT), (Earth stand =100% BW [AG] vs. 80° 
HUT), (Earth supine = 0% BW [AG] vs. 0° HUT).  
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Preliminary results from this study showed that cardiovascular effects from the two 
models were similar at the corresponding Alt-G body weights and HUT angles as shown 
above, especially as related to HR and cardiac output (CO) responses.  However, 
comparison between Alt-G and HUT data were difficult because it was not clear how much 
of the cardiovascular effect was from the air pressure inside the Alt-G chamber and how 
much was from the Alt-G shorts themselves.   
The hypothesis of the present study is that, by their nature (the shorts are tight), Alt-
G shorts result in fluid shifts towards the abdomen and thorax and significantly contribute to 
the increases in stroke volume, systolic and diastolic BP seen when lower body positive 
pressure is applied. At the same time heart rate should go down and total peripheral 
resistance should go up. 
Therefore the purpose of this study is to determine the effects of shorts on heart rate, 
systolic and diastolic blood pressure, mean arterial pressure, stroke volume, cardiac output, 
total peripheral resistance and volume shifts (as determined by thoracic, abdominal, upper 
and lower leg impedance) at 0 and 80 degrees head-up tilt. 
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Chapter Two 
Review of Literature 
 
The purpose of this literature review is to investigate past and current literature 
involving compression garments, the lower body positive pressure (LBPP) they create and 
their effect on the cardiovascular system (heart rate, blood pressure, stroke volume, cardiac 
output, total peripheral resistance, fluid shifts, etc) in normal and reduced gravity conditions, 
as experienced by astronauts. With respect to blood pressure, compression garments are 
used to treat orthostatic intolerance. Orthostatic intolerance (OI) and orthostatic hypotension 
(OH) are serious manifestations of adrenergic failure, occurring in the progressive 
autonomic disorders such as autonomic neuropathies, autonomic failure and multiple 
system atrophy (Denq et al., 1997). OI is a common problem in the aging population and 
affects ~30% of short duration and 80% of long-duration crewmembers post-flight  (Stenger 
et al., 2010). 
 
Therapeutic approaches to OI and OH primarily consist of the use of vasoconstrictor 
drugs, increasing blood volume and the use of compression garments. The latter method is 
the topic of our discussion.  
 
Crile introduced LBPP with the antigravity suit (G suit) or medical anti-shock trousers 
in 1903. The development of new materials since, allowed the fabrication of elastic suits that 
are able to apply evenly distributed or gradient pressures. However, there is little systematic 
information about the effects of compression of various venous capacitance beds. Testing of 
compression garments for their ability to provide a significant counter-measure to lower body 
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blood pooling in returning astronauts is in its infancy (Gaffney F. et al.,1981; Williamson, J. 
et al., 1994; Nishiyasu T. et al., 1998; Fu Q. et al., 2000) 
The efficacy of compression of specific compartments (calves, thighs, low abdomen, 
calves and thighs together, and all compartments combined) has been investigated by Denq 
J. et al., 1997. His study was carried out on 14 patients who were confirmed to have 
neurogenic OH. Each patient donned a modified (Crile) G suit which had five separate 
compartments: one lower abdominal, two thigh and two calf bladders. The suit was filled 
with air and a regulator connected to the bladders made it possible to control pressure 
continuously. In randomized order, the different bladders were inflated with a pressure of 40 
mmHg. Five minutes of data were recorded with each subject supine, as well as five minutes 
tilted at 80 degrees with or without the selected compartments inflated.  
One of the findings in the above study was that head-up tilt (HUT) resulted in a 
significant reduction in blood pressure (BP), cardiac output (CO) and total peripheral 
resistance (TPR).  However, the main finding was that compression of capacitance beds 
reduced significantly (p<0.01) the deficit in standing BP if both the legs and the abdomen 
(13/14 subjects) were compressed or if the abdomen alone was compressed (9/14), due to 
substantial amount of fluid in the human gut area. The improvement was due primarily to an 
increase in TPR. The improvement in BP was accompanied by improvement in orthostatic 
symptoms.  Compression in the region of calves, thighs or combined calves and thighs was 
not as impressive as compression of the abdomen. The degree of improvement correlated 
relatively well with the amount of blood in the regional vascular beds involved. On standing 
up there was an orthostatic shift of approximately 500ml of blood to the limbs. The 
splanchnic mesenteric bed is two- to three-fold larger, comprising 20-30% of total blood 
volume. In the postprandial state, there is a further increase of two- to three-fold.  
Presumably, improvement in TPR or BP did not occur with compression of the calves, thighs 
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or both, since the capacity of those regions was relatively small. Compression of the limbs is 
nevertheless important, since the combination of limb, with abdomen, compression 
increased the proportion of subjects with moderate to large improvement in orthostatic 
tolerance from 5/14 to 13/14.  Moreover, due to relatively low cost, comfort and ease of 
donning, lower limb compression garments continued to be investigated.  
In a study by Stenger M. et al., 2010, thigh-high, custom-fit, graded compression 
garments by “BSN-JOBST, Inc.” were used on five male astronauts following a 13-day 
mission to International Space Station (ISS). Graded compression consisted of 55 mmHg 
pressure at the ankle, degrading to ~18 mmHg at the knee and 6 mmHg at the thigh. These 
compression garments were worn beneath their flight suits during the Space Shuttle “walk 
around” and media events. Two hours after landing, the crewmembers participated in 
NASA’s operational test of orthostatic tolerance, which consisted of 6 min of supine rest 
followed by 80-degree HUT for 10 min or until the onset of presyncope. Hemodynamic 
responses to tilt in these crewmembers were compared to nine male astronauts (control 
group) who underwent an identical tilt test protocol in a different lab but without any 
compression garments.  As a result, following spaceflight, all astronauts wearing thigh-high 
compression garments completed the full 10 min HUT test. In contrast, only six out of nine 
subjects in the non-countermeasure group completed the tilt test without developing 
presyncopal symptoms. However, there was no statistically significant difference between 
the survival rates of the countermeasure and non-countermeasure groups (P=0.171). 
Systolic BP was not affected by position, but was elevated in the counter-measure group 
(P=0.006). Diastolic BP was not affected by position or group. HR was elevated by tilt 
(P<0.001), but was not different between groups. SV and CO were decreased by tilt 
(P<0.001), but were both significantly higher in the countermeasure group (SV, P=0.028; 
CO, P=0.017).  
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Therefore in that study, thigh-high, graded compression garments were an effective 
countermeasure in mitigating the symptoms of orthostatic intolerance by decreasing venous 
pooling of the calves and thighs, thereby improving venous return and stroke volume. That 
study had several limitations, first, only a small number of subjects (five astronauts) and no 
females were tested. In addition, although the compression garments were custom fit to 
each astronaut, the measurements were made pre-flight. Crewmembers often lose leg 
volume, through a combination of dehydration and muscle atrophy so the magnitude of the 
compression was probably less than originally intended. The level of protection from the 
compression garments used may be improved by the addition of abdominal or full body 
compression. 
Full-body compression suits showed the most significant effects, as in the study by 
Platts et al.. 2009, who compared NASA’s inflatable antigravity suit (AGS) and the Russian 
Federal Space Agency’s non-inflatable compression garment “Kentavr” (a.k.a. “Centaurus”).  
That study involved 35 male and female subjects, randomly assigned to one of the three 
groups, AGS, Kentavr or control (no counter-measure) groups. Thirty-six hours before the tilt 
test (0 degrees HUT to 80 degrees HUT), used to assess orthostatic tolerance, the subjects 
were dehydrated using a dose of furosemide (diuretic, 0.5 mg/kg) infused into an antecubital 
vein followed by a low salt diet (10 mEq Na+ per day).  As a result, all subjects wearing 
either AGS or Kentavr full body garments during the tilt test completed the test without 
symptoms of orthostatic hypotension. In contrast, only 56% of control subjects were able to 
complete the test.  
The tilt-induced decrease in systolic BP of control subjects (-16 ± 5 mmHg) was 
significantly greater than in AGS subjects (8 ± 4 mmHg) and Kentavr (2 ± 3 mmHg).There 
was no difference between countermeasure groups. The increase in HR was greater in 
8 
 
control subjects (38 ± 4 bpm) than in the AGS subjects (15 ± 3 bpm) and in the Kentavr (16 
± 2 bpm). The drop in SV at the end of tilt was significantly less in the AGS (21 ± 3 ml) 
compared to control subjects (36 ± 3 ml). Standing SV for the AGS and Kentavr subjects 
were significantly higher than for controls at the end of tilt.  Therefore, both the NASA AGS 
and the Russian Kentavr full body compression suits proved to be effective 
countermeasures against OH throughout passive tilt during pharmacologically induced 
hypovolemia. Wearing a compression garment reversed the effect of hypovolemia (as 
experienced after a space flight) on the response to tilt.  
Although both garments provided effective countermeasures, both have negative 
features. The AGS requires a compressed gas source to inflate the bladders and maintain 
compression. Once AGS is disconnected, the bladders slowly leak, especially during 
movement. In contrast, Kentavr is a non-inflatable garment that consists of elastic, laced 
bicycle type shorts and gaiters (which cover the calves), thus the area around the knees and 
groin are not compressed, which may lead to edema formation during chronic use (after 
landing and egress).  In addition, the utility of full-body suits could be decreased in some 
scenarios. For example, inflation of an AGS during emergency egress from the Space 
Shuttle may limit crewmember’s capacity to move to a safe distance from the vehicle by 
restricting movement in the lower body. Use of the AGS and Kentavr are complicated 
because both require aid from others crew members to don.  Both also interfere with the 
adult diaper worn by all astronauts under the advanced crew escape suit (ACES).  
Therefore additional research is needed in development of compression garments that can 
be optimized for crewmember protection without interfering with critical mission tasks. These 
garments are also quite expensive and would be quite impracticable for the general 
population with OI condition.  
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In addition to thigh-high and full-body garments, several studies focused on 
abdomen compression. While Denq et al.. 1997, used air-pressurized garments to improve 
blood pressure, comparison studies between the efficacy of air-pressurized garments versus 
elastic counterpressure with respect to orthostatic hypotension were not published until A. 
Smit et al.. 2004.  In the Smit study, 23 patients with neurogenic orthostatic hypotension 
underwent three protocols. Protocol 1 evaluated a 40-60degree HUT position and the effect 
of abdominal compression using an anti-gravity suit on caval vein and femoral diameter, 
arterial BP and hemodynamics. Protocol 2 documented the relationship between the level of 
compression and the arterial pressure response. Protocol 3 investigated the ability to 
maintain standing BP by an abdominal elastic binder. During HUT, compression (40 mmHg) 
resulted in a reduction in diameter of the caval vein without a change in femoral vein 
diameter while SV increased by 14%, CO by 13%, HR decreased by 4% and BP 
(systolic/diastolic) by 30%/14%, both p<0.05, with no change in TPR. Forty mmHg 
compression was associated with a higher blood pressure than 20 mmHg compression.  
Elastic abdominal binding increased standing BP with 15/6 mmHg (systolic/diastolic range -
3/3 to 36/14).  Elastic binding and air-pressurized binding increased standing BP to a similar 
extent.  However, in some patients in above study, low level abdominal compression did not 
increase standing BP. Hypothetically, the distribution of disturbed autonomic innervation and 
thereby capacity for venous pooling in the abdomen, differs among patients.. Further studies 
are needed to assess whether, and how, the efficacy of abdominal compression can be 
optimized. 
As in the study above, the present study focuses on a garment that compresses the 
abdominal area with the use of Alt-G shorts. The Alt-G shorts are an integral part of the Alt-
G treadmill, which uses LBPP to reduce body weight and therefore simulate reduced gravity.  
In the Alt-G, the subject, wearing special Alt-G shorts is sealed at the waist inside the LBPP 
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enclosure and positive air pressure is applied to the subject’s lower body while they stand, 
walk or run on an enclosed treadmill.  The selection of Alt-G shorts as a compression 
garment in this study was based on several other studies (Evans JM et al.., 2010, Kostas V. 
et al.., 2011 – in progress to be published), which compared cardiovascular effects between 
Alt-G and HUT models of reduced gravity. Specifically, data obtained at four body weights 
(BW) produced by the Alt-G were compared to data acquired from four degrees of HUT 
(Moon stand=20% Gz BW [AG] vs 10° HUT, Mars stand=40% Gz BW [AG] vs. 20° HUT, 
Earth stand =100% Gz BW [AG] vs. 80° HUT, Earth supine = 0% Gz BW [AG] vs. 0° HUT).  
Results from this study showed that cardiovascular effects from the two models were similar, 
especially as related to HR responses and CO.  However, comparison between Alt-G and 
HUT data were difficult because it was not clear what percentage of the cardiovascular 
effect was from the air pressure inside the Alter-G chamber and how much was from the Alt-
G shorts themselves.   
The hypothesis of the present study is that, by their nature (the shorts are tight), Alt-
G shorts result in fluid shifts towards the abdomen, and significantly contribute to increases 
in stroke volume and systolic BP and reduction of heart rate when lower body positive 
pressure is applied.  A secondary purpose of this study is to provide insight into effects of 
the compression shorts on results from the simulated Moon and Mars gravity environments 
study (Kostas V. et al., 2011). In that study subjects inside the Alt-G treadmill were affected 
by LBPP but how much of that effect was contributed by the shorts themselves was 
unknown. Finally, another purpose was to determine how effective the Alter-G shorts were 
in preventing symptoms of orthostatic intolerance in comparison to compression garments 
used in other studies. 
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Chapter Three 
Methodology 
           
The subjects in this study were 12 healthy, non-smoking, properly-hydrated adults, 6 
male and 6 female (height=176.9±3.5 cm, weight=77.4± 6 kg, mean ± S.E.M.). They were 
recruited by word of mouth. While subjects of any ethnic background were recruited, all 12 
subjects were Caucasian, between 18 and 45 years of age (age=27.2±2.5, mean ± S.E.M.). 
Subjects were excluded if they failed any of the criteria in the qualification phase provided 
below. 
 The study was approved by University of Kentucky Institutional Review Board. All 
subjects gave written informed consent prior to participation.  The study took place at the 
University of Kentucky Aeronautical Research Laboratory, “Wenner-Gren” Center for 
Biomedical Engineering. 
 
 
Protocol:       
 
Subjects were asked to complete several phases in one session (one day) lasting no 
longer than 1.5 hrs total. 
 
Qualification Phase: 
 There was an initial screening/qualification phase lasting 20 minutes. The screening/ 
qualification included signing of the Informed Consent Form, Physical Activity Readiness 
Questionnaire (Par-Q) and BP measurement.  If the subject answered “Yes” to any of the 
Par-Q questions or had prior history of fainting, they were excused from participation. If 
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resting BP was greater than 140/90 mmHg, they were excused with a recommendation to 
see a physician.  
  This phase also identified caffeine users and their approximate daily intake, as well 
as smokers. Participants were asked about the amount of exercise they performed before 
the study, their sweat rate, as well as fluid intake. This information was used during the data 
interpretation phase to determine if any of these activities/conditions had a significant 
influence on results. 
 
Orientation Phase: 
Subjects who passed the initial screening were allowed to participate in the study 
following a verbal orientation.  In this phase, the subject’s height (“American Std., Union, 
WA”) and weight (“Taylor Professional Scale”, Crestwood, VA) were recorded.  Body cross 
sectional area at hip, waist and thigh were measured using a measuring tape.  Then 
subjects were fitted with “Alter-G” (“Woodway, Alter-G-SML”) LBPP garments of various 
sizes (S, M, L, XL, XXL). The Alter-G (Alt-G) shorts had to fit tightly and comfortably on the 
subject’s body (Fig. 3.1).  If a subject’s physique did not allow them to fit in any of the 
garments available onsite, they would have been excused.  Criteria for elimination were 
unusually large or small waist or thigh circumference which would have made the garments 
uncomfortably tight or too loose. None of the recruited subjects were excused. 
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Fig. 3.1. Subject fitted with Alt-G shorts. 
 
Subjects were also familiarized with the HUT table operation and impedance/ECG 
electrode placement. The orientation phase lasted about 20 minutes.        
       
Preparation / Instrumentation Phase: 
The order of stages/conditions (stage 1/with shorts or stage 2/without shorts) as well 
as order of HUT angle/activity (0 degrees/supine or 80 degrees/standing) was randomized 
and entered into a matrix in such a manner that an equal number of subjects, both male and 
female, participated in each activity and each condition. This was accomplished by dividing 
the total number of subjects in half, as well as dividing male and female in half, and 
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randomly assigning subjects from each half to each condition. The matrix for 12 subjects is 
shown in Table 3.1. 
 
Table 3.1. Order of HUT activities matrix for male and female subjects.         
 
Subjects were asked to either wear or not wear the Alt-G shorts, according to the 
matrix above.  Then he/she was asked to lay or stand still on the HUT table (“Bailey Mfg. 
9505”, Louisville, KY) according to the matrix, while all devices were calibrated, Fig. 3.2. 
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Fig. 3.2. Subject supine (HUT0) during tilt test. 
 
The subject’s left arm was placed on a platform at heart level for accurate BP 
measurements and strapped to the platform with “Velcro” to prevent movement. The 
subject’s legs and abdomen were strapped to the HUT table to prevent shifting or falling 
during tilting. 
For placing the ten impedance leads, appropriate skin areas were treated with 
alcohol and shaved (with subject’s permission). Monitoring electrodes (“3M, Red Dot -2560”) 
were placed as follows: lead 1 on back of the neck, lead 2 on top of left foot, lead 3 on right 
shoulder, leads 4 and 5 under left rib, leads 6 and 7 on left upper thigh, lead 8 above left 
knee, lead 9 below left knee, lead 10 on lower leg, above the foot.  The segment between 
leads 3 and 4 determined the fluid in the thorax, between leads 4 and 7 – in the abdomen, 
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between 7 and 8 – in the upper leg, between 9 and 10 – in the lower leg as shown in Fig. 
3.3. 
 
      Fig. 3.3. Electrode placement on subjects for determining impedance. 
 
 
Impedance leads detected segmental tetrapolar body impedance (“Thrim Tetrapolar 
Impedance Meter – 2994”, San Francisco, CA) which was transmitted to a “Dell” laptop 
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(“Dell Latitude D-600”).  Lengths of each of the four body segments were measured with a 
tape and data were recorded for later use in impedance formulas for each subject 
(thorax=39.6±1.0 cm, abdomen=45.3±1.8 cm, upper leg=23.9 ± 1.1 cm, lower leg=24.5± 1.4 
cm, mean ± S.E.M.) 
 The five ECG leads were placed as follows: one on right shoulder, one on left 
shoulder, one above left hip, one above right hip and one on chest. The ECG leads were 
connected to the ECG unit (“Spacelab”) which in turn transmitted data to the laptop. 
 The continuous BP device consisted of a small cuff with a “Portapres” sensor, fitted 
on the subject’s middle finger according to size (S, M, L, XL) and connected to the “FMS 
Portapres” front end unit (“Finapres Medical Systems”) which was secured to the subject’s 
wrist with Velcro to prevent sliding. In turn, this unit transmitted data to the computer. The 
technology used by the Finapres Medical Systems finger BP device is based on the volume-
clamp method, first introduced by Czech physiologist J. Penaz in 1967.With this method, 
finger arterial pressure is measured using a finger cuff and an inflatable bladder in 
combination with an infrared plethysmograph, which consists of an infrared light source and 
detector. The infrared light is absorbed by the blood and the pulsation of arterial diameter 
during a heart beat causes a pulsation in the light detector signal. A special algorithm then is 
able to determine the blood pressure wave form. 
The ECG, impedance and BP device signals transmitted to the computer were 
monitored on the screen using “Windaq” software (“Windaq Pro Data Acquisition Sftw. V. 
2.59” and “Windaq Playback”, “DATAQ Instruments”, DI-7x0 USB0).  In addition, subjects 
were fitted with a cuff around the left bicep connected to a manual BP/HR device (“AND UA 
– 767”) for validation of “Portapres” BP and “Spacelab” ECG data. 
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The temperature in the room was monitored using a “LaCrosse Technologies” 
thermometer.  The preparation/instrumentation phase duration was 20 minutes. 
 
Measurement/Data Acquisition Phase: 
This phase included confirmation of working condition of all devices.  Subjects were 
asked to lay still and not talk for five minutes at a time while data acquisition (length=three 
minutes) took place in each of the four conditions from matrix above. The tilting of the table 
took less than one minute between all conditions (Fig. 3.4). Time allotted for equilibration of 
fluids and cardiovascular variables between activities took one minute,  while changing 
into/out of shorts took about five minutes, with a total of about 20 minutes for the data 
acquisition phase. 
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Fig. 3.4.  Data acquisition while subject is tilted to HUT80.  
 
Measurements of subjects’ HR (both ECG and manual BP device), BP (SBP, DBP 
and MAP, both continuous and manual), TPR, fluid shifting measurement/ segmental body 
impedance (thoracic, abdominal, upper leg and lower leg segments) took place at this time.  
All manual data were hand-written into each subject’s data sheet.  
 Automated signals were collected and monitored using pre-set channels in Windaq 
Software on the computer, as shown in Fig. 3.5, where channel 1=ECG data, channel 2 = 
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BP data, channel 3 = HR, channel 4 = thorax Delta RO (changes in impedance of the thorax 
filtered to give respiratory impedance), channel 5 = d RO / dt (derivative of impedance 
filtered to give heart synchronous impedance), channel 6 = thorax RO (raw impedance of 
the thorax), channel 7 = abdomen RO (impedance of the abdomen), channel 8 = upper leg 
RO (impedance of the upper leg), channel 9 = lower leg RO (impedance of the lower leg). 
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Fig. 3.5.  “Windaq” file with signals from 9 channels for one subject. 
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Each signal from subjects’ “Windaq” file was analyzed with “Physiowave” Software 
(“Physiowave 6.21, Visual Numerics Corp.”).  Each signal was filtered and transformed 
through derivation formulas with sample frequency of 1000Hz, with low bandpass filter = 
0.5Hz and high bandpass filter=20Hz.  “Physiowave” software was also used to perform 
signal peak detection and to insert new markers into the Windaq file to indicate R-R interval, 
minimum and maximum values, etc.  Beat-to-beat and breath-to-breath tables were 
generated. Spectral analyses of R-R intervals and BP were performed.  
Even though each activity contained approximately 180-200 sec worth of data, 
cleanup reduced it to about 130 sec of good data. The cleanup consisted of removal of bad 
data (from calibration, from artifact, from weak signal and/or from loose electrodes). The 
remaining data were averaged through Physiowave for each activity/condition and imported 
into Excel (Miscrosoft Office Excel 2003). 
 
Statistical Analysis 
Data were analyzed in Excel and also imported into SAS (SAS Enterprize Guide v. 
4.2, SAS Institute Inc.) for statistical analysis.  To evaluate the effect of shorts, a paired two-
sample t-test of the change in the mean for each change in condition (for example the 
change from HUT0 to HUT80 was compared for shorts vs. no shorts condition). This test 
was chosen over any other test, like an ANOVA, due to limited amount of subjects and large 
variability between subjects. Data were expressed as means ± S.E.M.  The hypothesis that 
the shorts condition would be different from the no shorts condition was tested for each 
activity.  Significance was rejected when p>0.05. 
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Chapter Four 
Results 
 
Six male and six female subjects, all Caucasians, passed all qualification criteria and 
successfully completed the study over an 8-week period. Subject demographic data are 
shown in Table 4.1. 
 
Table 4.1. Age, sex, height and body mass of the 12 subjects.  
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Inter-subject variability was high for all measurements. Age varied from 18 to 45 with 
an average of 27.2 years. Height ranged from 162.6 to 193.0 cm with an average of 176.9 
cm. Weight range was 47.6 kg to 120.7 kg with an average of 77.4 kg.  Temperatures in the 
room varied between 77.5 and 79.2 F during testing. 
Effects of the tilt tests on HR, BP and impedance measures with and without the 
compression shorts are shown in Table 4.2. The values have been averaged for twelve 
subjects with standard error of the mean shown. 
 
 
Table 4.2. Resulting cardiovascular mean values ± S.E.M. 
The effect of shorts on each cardiovascular variable is shown in each of the 
corresponding sections below. 
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 Effect of Shorts and HUT on HR 
 
Effects of shorts and HUT on HR are shown in Fig. 4.1. Without shorts, the average 
HR was 66.4 ± 4.8 bpm supine (HUT0), which is the control condition.  Tilting to 80 degrees 
(HUT80) caused HR to increase to 91.5 ± 7.7 bpm. A similar effect was seen when the 
subjects wore shorts, where the average HR increased from 64.0 ± 4.1 bpm at HUT0 to 84.8 
± 6.7 bpm at HUT80. The tilt effect was significant, both with and without shorts (p<0.05). 
The tilt effect on HR was in line with that seen in other studies (Denq et al., 1997; Platts et 
al., 2009; Stenger et al., 2010). 
 
When examining the effect of shorts, notice that the tilt-induced increase in mean HR 
was smaller when subjects wore the Alter-G shorts.  The shorts reduced HR by 2.3 bpm in 
the supine and by 6.7 bpm in the HUT80 position.  The paired t-test was used to test the 
change in HR with shorts and no shorts.  This method was selected because it provided the 
most sensitive indicator considering the following factors: 1) small effect of stimulus (shorts), 
2) small number of subjects, 3) large inter-subject variability (see Table 4.1).  In the case of 
HR, the change in means between ∆shorts =25.1 bpm vs. ∆no shorts =20.7 showed that the 
effect of shorts was statistically significant (p<0.05).   
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Figure 4.1. Mean heart rate of twelve subjects with and without Alter-G shorts 
at HUT0, HUT80.   * Effect of tilt significant.    # Change in HR significantly less 
with shorts than without shorts. 
 
Effect of Shorts and HUT on SBP  
 
Effects of shorts and HUT on SBP are shown in Fig. 4.2.  Without shorts, the 
average SBP decreased from 117.3 ± 4.5 mmHg supine at HUT0 to 106.4 ± 5.1 mmHg at 
HUT80. A similar effect was seen when subjects wore shorts. The average SBP decreased 
from 115.9 ± 3.8 mmHg at HUT0 to 109.3 ± 4.4 mmHg at HUT80. While the changes in 
* 
 
# 
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blood pressure could be of physiological significance, they were not statistically significant 
due to large standard deviations (p>0.05). However, the effect of tilting on SBP was in line 
with that seen in other studies (Denq et al.; 1997, Platts et al.; 2009, Stenger et al., 2010). 
 
When examining the effect of shorts, notice that the tilt-induced decrease in mean 
SBP was smaller when subjects wore the Alter-G shorts, basically the shorts had the effect 
of maintaining control SBP during tilt. The shorts reduced SBP by 1.3 mmHg in the supine 
and increased it by 2.9 mmHg in the HUT=80 position (a net effect of 4.2 mmHg). The 
paired two sample t-test for change in means between ∆shorts = 6.6 mmHg vs. ∆no shorts = 
10.8 mmHg showed that the effect of shorts on SBP was statistically significant (p<0.05). 
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Fig. 4.2.  Mean systolic blood pressure with and without shorts.   # Change in 
SBP significantly less with shorts than without shorts. 
 
Effect of Shorts and HUT on DBP  
 
Effects of shorts and HUT on DBP are shown in Fig. 4.3. In the supine position 
without shorts, the average DBP was 71.2 ± 2.4 mmHg.  Tilting to 80 degrees decreased the 
average DBP to 67.0 ± 3.2 mmHg. A similar effect was seen when the subjects wore shorts. 
The average DBP decreased from 70.1 ± 2.5 mmHg at HUT0 to 65.9 ± 3.5 mmHg at 
HUT80. Neither tilt nor shorts effects were significant on DBP. 
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Fig. 4.3.  Mean diastolic blood pressure with and without shorts.  No significant shorts 
effect.  
 
 
Effect of Shorts and HUT on Mean Arterial Pressure  (MAP) 
 
Effects of shorts and HUT on MAP are shown in Fig. 4.4. In the supine position 
without shorts, the average MAP was 86.5± 3.1mmHg . Tilting to HUT80 decreased average 
MAP to 80.1 ± 3.8 mmHg. A similar effect was seen when the subjects wore shorts. The 
average MAP decreased from 85.3 ± 3.0 mmHg at HUT0  to 80.3 ± 3.8 mmHg at HUT80 
degrees. The tilt effect was not significant, neither with nor without shorts (p>0.05).  
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Fig. 4.4.  Mean arterial blood pressure with and without shorts.  No significant tilt nor 
shorts effect. 
 
 
Effect of Shorts and HUT on Segmental Impedance Change  
 
Measurements of Impedance were performed for several reasons. Due to the 
inverse relationship between impedance and fluid volume (Formula 4.1), the higher the 
impedance value, the less fluid that is in the measured area/segment and vice versa: 
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 Vol = L² * δ / R,  
Formula 4.1. Fluid volume and Impedance/resistance formula (where L = 
segment length, δ = effective resistance for plasma (0.8 – 1.0 Ohm), R = 
segment Impedance (device measured)).  
 
Tracking the changes in fluid volume (of blood, interstitial fluid, etc) allows us to 
explain why the human cardiovascular system responds the way it does to the tilt and to 
compression by shorts. In addition, impedance is used to calculate heart stroke volume and 
cardiac output, using the Sramek-Bernstein formula 4.2. 
 
SV = δ * ((0.17*H)3 /4.25) * ( dZ/dtmax /Z0) * LVET 
 
Formula 4.2. Sramek-Bernstein formula for calculating stroke volume (SV), 
where δ is a weight correction factor, H- person’s height, dZ/dtmax – maximal 
impedance change, Z0 – basic thoracic impedance, LVET – left ventricular 
ejection time. 
 
Effects of shorts and HUT on segmental impedance in thorax (THX), abdomen 
(ABD), upper leg (UL) and lower leg (LL) are shown in Fig. 4.5.  In the case of THX, looking 
at the tilt alone, notice that without shorts, THX impedance, R0 (Fig. 4.5.A) averaged 14.8 ± 
1.3 Ohm at HUT0, which is the control condition.  Tilting to HUT80 did not increase the 
average THX R0 significantly.  A similar trend was seen when subjects wore shorts.  
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Fig. 4.5. Mean segmental impedance response. 
 
In the case of ABD, looking at the tilt alone, notice that without shorts, ABD 
impedance, R0 (Fig. 4.5.B) averaged 30.1 ± 1.9 Ohm at HUT0.  Tilting to HUT80 decreased 
the average ABD R0 to 27.1 ± 1.5 Ohm, which means more fluid volume was available in 
this segment. A similar trend was seen when the subjects wore shorts. The average ABD R0 
decreased from 35.9 ± 3.4 Ohm at HUT0 to 30.2 ± 2.9 Ohm at HUT80. Neither the tilt effect 
nor the shorts effect on ABD was significant (p>0.05).  
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Looking at UL R0(Fig 4.5.C) and LL R0 (Fig. 4.5.D), although both the tilt and the 
shorts did lower overall impedance, neither the tilt nor the presence of shorts produced any 
statistically significant effects (p >0.05).   
 
 
Effect of Shorts and HUT on stroke volume (SV)  
 
SV was calculated using the Sramek-Bernstein formula, 4.2.  The effect of shorts 
and HUT on SV are shown in Fig. 4.6. Without shorts, the average SV was 69.3 ± 4.2 ml at 
HUT0.  Tilting to HUT80 decreased the average SV to 33.2 ± 1.9 ml. A similar effect was 
seen when the subjects wore shorts. The average SV decreased from 72.3 ± 4.1 ml at 
HUT0 to 36.2 ± 1.9 ml at HUT80. The tilt effect was significant (p<0.05).  
 
When examining the effect of shorts, notice that overall the shorts increased SV by 
3.0 ml in the supine and increased it by the same amount (3.0 ml) in the HUT80 position. 
The paired two sample t-test for change in means between ∆shorts vs. ∆no shorts showed 
that the effect of shorts on SV was not statistically significant (p>0.05). 
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Fig. 4.6.  Mean stroke volume with and without shorts.  * Significant tilt effect.    
No shorts effect. 
 
 
Effect of Shorts and HUT on Cardiac Output (Q) 
 
Cardiac output was calculated using the following formula:  
Q = HR  *SV / 1000 
Formula 4.3. Formula for calculating cardiac output (where HR=heart rate and 
SV=stroke volume (see formula 4.2)) 
25.00
30.00
35.00
40.00
45.00
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
HUT0 HUT80
HUT angle (deg)
St
ro
ke
 V
ol
um
e 
(m
l)
No Shorts
With Shorts
* 
35 
 
Effect of shorts and HUT on Q is shown in Fig. 4.7. Without shorts, the average Q 
was 4.6 ± 0.2 L/min at HUT0.  Tilting to HUT80 decreased the average Q to 3.1 ± 0.2 L/min. 
A similar effect was seen when the subjects wore shorts. The average Q decreased from 4.6 
± 0.2 L/min at HUT0 to 3.1 ± 0.2 L/min at HUT80. The tilt effect was significant (p<0.05), but 
the shorts themselves had no effect on Q. 
 
Fig. 4.7.  Mean cardiac output with and without shorts.   * Significant tilt effect.    
No shorts effect. 
 
 
 
 
 
* 
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Effect of Shorts and HUT on total peripheral resistance (TPR) 
TPR was calculated using this formula:  
TPR=MAP/Q 
Formula 4.4. Formula for calculating total peripheral resistance (where 
MAP=mean arterial pressure and Q=cardiac output) 
Effects of shorts and HUT on TPR are shown in Fig. 4.8.  Tilting subjects to HUT80 
caused a significant increase in TPR, but wearing shorts had no effect.  
 
   Fig. 4.8.  Mean total peripheral resistance with and without shorts.   
   * Significant tilt effect.     No shorts effect. 
 
 
* 
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Chapter Five 
 
Discussion 
 
The present study was designed to determine the physiological effects of the Alter-G 
compression shorts on cardiovascular parameters during supine resting and head up tilt.  
The hypothesis of the present study was that, by their nature, Alter-G shorts would result in 
fluid shifts toward the abdomen or thorax, and significantly contribute to maintaining stroke 
volume and systolic BP when the body is tilted (to simulate what happens to astronauts 
upon return from microgravity to Earth). The main finding of this study was that, as seen in 
Fig. 4.2, the shorts significantly attenuated a reduction in SBP, compared to no shorts 
condition. However, this increase in SBP did not manifest itself with any significant change 
in stroke volume (SV), (see Fig. 4.6), nor with any significant changes in cardiac output (Q) 
(see Fig. 4.7) during the tilt test. Instead, a major change was found in heart rate (HR), (see 
Fig. 4.1), especially at 80 degrees tilt, where the HR was lower on average by 6.7 bpm when 
subjects wore shorts vs. the condition without shorts.  The lower HR is possible due to 
higher stroke volume, even though it could not be determined exactly due to impedance 
formula used (see Formula 4.2). 
 
In this small group of subjects, the Alter-G compression garments were an effective 
countermeasure to mitigate symptoms of orthostatic intolerance and pre-syncope 
throughout passive upright tilt by maintaining SBP. Compared to thigh-high or knee-high 
garments from other studies (Stenger et al., 2010), these symptoms were not prevented by 
decreasing venous pooling in the legs, which in turn improved venous return, SV and Q. 
Instead, the abdomen contains a large, highly compliant, venous bed which contains 
approximately 25% of the blood volume at rest. During orthostasis, its capacity is reduced 
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by baroreflex-mediated arteriolar vasoconstriction (Rowel, et al., 1972). Compression of the 
abdomen increases intra-abdominal pressure and thereby reduces vein diameter (Holcroft, 
et al., 1984) and splanchnic blood volume. Measurements in healthy subjects and 
autonomic dysfunction patients from other studies disclose that the subsequent abdomino-
thoracic blood shift increases thoracic blood volume (see Impedance Fig. 4.6 A and B) and 
central venous pressure (Smit, et al., 2004). This leads to a better filling of the heart and 
increases SV and Q. In this study Q did not change significantly, as the increase in SV was 
offset by the drop in HR.   
 
Note, that in all literature on this subject there is excellent agreement that positive 
pressure raises BP, and that there is a reduction in volume and flow in the compressed 
region (Denq et al., 1997). However, there is some disagreement in the literature on the 
mechanism of improvement, as to whether the effect is mediated by increasing peripheral 
resistance alone, i.e. afterload increase (Tenny S.M., et al. 1955) or by improving venous 
return, i.e. preload increase (Tanaka H., et al., 1996). The findings from our study seem to 
adhere to the last group, although the results are inconclusive, since as we have seen, 
preload has increased and stroke volume was higher, although by an insignificant amount.  
 
As far as the effects of tilt alone are concerned, this study was in line with other 
studies (Denq et al., 1997, Platts et al., 2009, Stenger et al., 2010) which looked at 
cardiovascular responses of subjects tilted from 0 degrees to either 70 or 80 degrees. The 
tilt test was administered as it mimics very closely weightlessness (at 0 degrees tilt) and also 
Earth gravity (at 70 or 80 degrees tilt) and allows the investigator to examine fluid shifts 
within the subject’s body while it changes angle, as well as its effect on the cardiovascular 
system. The tilt was performed passively, while subjects were resting on the tilt table with 
their feet on a sturdy platform. They were quiet without any talking, movement or muscle 
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contractions which could trigger venous return from lower extremities, therefore minimizing 
effects  of external influences on Q and SV. As expected, HR increased after the tilt 
(significantly, in this study), as more fluid shifted toward lower extremities, the heart had to 
work harder to return blood to the upper body; systolic (SBP), diastolic blood pressures 
(DBP) and mean arterial pressure (MAP) decreased slightly, while SV and Q decreased 
significantly. Total peripheral resistance (TPR) increased significantly with the tilt.  
 
Looking at segmental impedance (Fig. 4.7 A, B, C, D), thorax (THX) impedance 
increased slightly with the tilt. Due to an inverse relationship between impedance and fluid 
volume (see Formula 4.1) less fluid was present in the thorax after the tilt. Most of that fluid 
shifted into the abdomen, as confirmed by (not significantly) lower abdominal impedance 
(Fig. 4.5. B) (therefore, higher fluid volume), while some went into upper leg and lower leg 
segments, as shown by slightly lower impedance in those segments during tilt (Fig. 4.5. C 
and D). The presence of compression shorts during the tilt led to more fluid being retained in 
the thorax (Fig. 4.5 A) and less left in the abdomen (in addition to thorax, some of the fluid 
went from the abdomen into the upper and lower leg segments). A possibility for a future 
study would be to add compression socks which could possibly increase venous return and 
affect stroke volume, heart rate and other cardiovascular variables, but that could be a topic 
of research for another study. 
 
A secondary purpose of this study was to separate effects of the compression shorts 
from effects of Alter-G lower body positive pressure created by air pressure and in turn 
provide answers to questions from the comparative study of simulated Moon and Mars 
gravity environments between Alter-G and head-up tilt (Kostas V., et al., 2011). While no 
data from the Alter-G were collected during the present study, we can speculate on the 
effects, based on comparing the findings of a previous study, to data collected here. For 
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example, in the previous study (Kostas., et al., 2011), the average difference between 
systolic blood pressure at 100% body weight (up-right subject in Earth gravity) in the Alter-G 
(117.3 mmHg) versus 80 degree head-up tilt (104.1 mmHg) was 13.12 mmHg. From the 
results of the present study we can estimate that approximately 4.0 mmHg of the pressure 
changes were due to the shorts and approximately 9.0 mmHg was due to air pressure inside 
the Alter-G chamber. 
 
There are several limitations to this study. First, the study was conducted using a 
small number of subjects and inter-subject variability was high.  For example, subject 4 was 
a 20 y.o. female 177.8 cm high and weighing 120.7 kg, while subject 12 was a 28 y.o. 
female 162.6 cm high and weighing 47.6 kg. Secondly, the compression garments were not 
custom fit to each subject, as is the case in other studies. Instead, the garments in this study 
came in only 5 sizes (S, M, L, XL, XXL) and some subjects possibly had garments that were 
not an exact fit, which could have distorted the results.  The tightness of shorts was 
determined by using the index finger and pulling slightly on the shorts, both around legs and 
waist. This was a very subjective measurement and did not take into consideration other 
factors, like the circumference of the thighs or the waist and other factors. To better control 
for this variable, an improvement could have been to design a bladder device that would 
have been inserted between the subject’s skin and the Alter-G shorts and could be used to 
determine the direct pressure exerted by each pair of shorts on the subject’s skin.  This 
might have allowed a determination of a relationship between the pressure exerted by the 
shorts and changes in physiological parameters. Finally, the values for stroke volume, and 
subsequently for cardiac output (Q = HR*SV/1000) and TPR (TPR= MAP/Q) were obtained 
from the Sramek-Bernstein electrical impedance formula (see Formula 4.2). This method for 
determining SV was used due to its non-invasiveness and low cost.  Note that this formula 
assumes that the volume of the electrically participating tissue in the thorax is a truncated 
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cone, while other similar equations, (like Kubicek’s, SV = δ * (L2 / Z02) * ( dZ/dtmax /Z0) * 
LVET, where L- distance between electrodes) assume it is a cylinder. The validity of 
these SV equations has been investigated by many researchers (Woltjer, H. et al., 1997; 
Donovan K.D., et al., 1986). In general, most investigators have found a significant 
correlation (assuming normal hydration levels of subjects) between SV measured with 
impedance cardiography and SV measured with other methods, such as MRI or echo-
cardiography (ultra-sound), which were not available for this study due to their high cost. 
However, various investigators also reported a wide dispersion of the impedance SV data 
(Goldstein et al., 1986). It also appears from these studies that the impedance method is not 
equally valid under all physiological conditions. Thus, no consensus can be reached on the 
accuracy of impedance cardiography in measuring of SV. In some studies, the method is 
evaluated as highly accurate (Koon-Kang, et al., 1985); in others more dispersion between 
the two methods is found (Donovan, et al., 1986). In most studies, however, the mean 
difference between the two methods and its standard deviation are not shown, which makes 
it difficult to draw conclusions about precision. In order to establish the validity of impedance 
cardiography, more research is needed and more studies need to be performed comparing 
both impedance methods with each other and with other methods (MRI, echo-cardiography, 
etc).  
 
One such attempt was made in the comparative study of simulated moon and Mars 
gravity environments between Alter-G and head-up tilt (Kostas, et al., 2011). The average 
values for SV in that study were obtained using two methods, through ultra-sound and also 
using the impedance formula. Even though in absolute terms, the average SV values were 
different (92 vs. 190.5 ml for HUT0 degrees, as well as 63.8 vs. 140.6 ml for HUT80 
degrees, ultra-sound vs. impedance respectively), the relative change from HUT0 degrees 
to HUT80 degrees was in the same vicinity, 30.6% vs. 26.2%, ultra-sound vs. impedance 
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respectively. Therefore the absolute values for average SV obtained in current study (72.3 
vs. 36.2 ml, HUT0 to HUT80 degrees, respectively), could be ignored, since they are on the 
low side, and instead, the relative change of 50% of going from HUT0 degrees to HUT80 
should be taken into account.  
 
Based upon results obtained from this study, the level of protection from Alter-G 
compression shorts may be improved in future studies by the addition of thigh-high 
compression, as demonstrated by Denq et al., 1997, or breast-high compression. However, 
re-designing the Alter-G shorts to become Alter-G socks or pants or a full-body Alter-G suit, 
may also change lower body positive pressure exerted on the subject by the Alter-G air 
enclosure. During unweighting in the Alter-G device, with the shorts on, most of the pressure 
is concentrated in the perineum region of each subject, which also makes it quite 
uncomfortable over time, especially for males, as it may lead to edema. Switching to Alter-G 
pants with feet would most likely redistribute the pressure from the perineum to the soles of 
the feet and other body parts to make it more comfortable for subjects to withstand the 
unweighting process. More research is needed in the area of compression garments as it 
relates to simulating spaceflight and re-entry into Earth gravity using the Alter-G device, as 
well as well as for the purpose of other Earth related activities, such as athlete rehabilitation 
and injury prevention. 
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Chapter Six 
 
 
Summary and Conclusions 
 
 
 
The present study was designed to determine physiological effects of the Alter-G 
compression shorts while resting in the supine position and during a head-up tilt position.  
The main finding of this study was that the shorts significantly increased SBP by 
approximately 4 mmHg when compared to the no shorts condition during tilt. However, this 
increase in SBP did not manifest itself with any significant change in stroke volume (SV), nor 
with any significant changes in cardiac output (Q).  Instead, a major change was found in 
heart rate (HR), especially at 80 degrees tilt, where the HR increased 6.7 bpm less in 
subjects wearing the shorts. The smaller increase in HR could be due to higher stroke 
volume, even though this could not be established from the data we obtained. 
 
In this small group of subjects, the Alter-G compression garments were an effective 
countermeasure to mitigate the severity of the symptoms of orthostatic intolerance and pre-
syncope 
throughout passive upright tilt by maintaining SBP. As far as the effects of the tilt alone are 
concerned, this study was in line with other studies performed on this topic. 
 
A secondary purpose of this study was to separate effects of the compression shorts 
from effects of Alter-G lower body positive pressure created by air pressure and in turn 
provide answers to questions from the comparative study of simulated Moon and Mars 
gravity environments between Alter-G and head-up tilt. From the results of this study we 
were able to estimate that approximately 4.0 mmHg of the pressure changes were due to 
the shorts and approximately 9.0 mmHg was due to air pressure inside the Alter-G chamber. 
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Based upon results obtained from this study, the level of protection from Alter-G 
compression shorts may be improved in future studies by the addition of thigh-high 
compression, or breast-high compression.  More research is needed in the area of 
compression garments as it relates to simulating spaceflight and re-entry into Earth gravity 
using the Alter-G device, as well as well as for the purpose of other Earth related activities, 
such as athlete rehabilitation and injury prevention. 
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Appendix A 
 
 
 
Recruitment Script 
 
 
 
 
My name is Vladimir Kostas and I am Master’s Degree student in Exercise 
Physiology at the University of Kentucky. I am studying how the human body responds to 
microgravity, in particular what astronauts’ heart and blood go through in long duration 
space flights, as well as upon re-entry into Earth atmosphere and how various garments 
could decrease the negative effects of space-flight and allow humans to reach such far-
away worlds as Planet Mars and beyond. 
 
I am trying to find healthy subjects between the ages of 18 – 45 to participate in my 
study. To participate in this study, you must be overall healthy, without prior history of 
fainting. If you are pregnant, had major surgery within the past year, your doctor has 
restricted you from activity, you know your resting blood pressure is above 140/90, or if you 
have an HIV/AIDS diagnosis, you should not participate. 
 
The study will take place at the Biodynamics Laboratory in the center for Biomedical 
Engineering on the University of Kentucky campus. You will need to come to the 
Biodynamics Laboratory one time during the study. The visit will take about 1.5 hrs. You will 
be asked to try on lower body compression garments of various sizes, lay or stand still while 
your Heart Rate, Blood Pressure and other measurements are taken on a tilt table.  
 
You will be compensated for your time in the amount of $25. 
 
If you are interested in participating, feel free to contact me for more information 
(859)227-2074 or through email vlad.kostas@uky.edu (preferred method) 
 
Thank you ! 
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Appendix B 
 
 
Research procedures 
 
 
      Qualification Phase: 
- signing of the informed consent  ____________ 
- Par-Q questionnaire   _________________ 
- Medical history/history of fainting  __________ 
- Exercise the day of testing /sweat rate  ____________ 
- Fluid intake the day of testing  ____________ 
- BP measurement   ______________ 
 
      Orientation Phase: 
- verbal orientation / questions/ answers  _____________ 
- fitting with Alter-G shorts   ____________________ 
        
      Preparation / Instrumentation Phase: 
- record height   _______________ cm 
- record weight      ________________  kg 
- determine order of activities according to table/matrix  ___________ 
- Place subject on HUT table (HUT = 0 deg)___________ 
- Place ECG and IMPDN electrodes / connect leads  _________ 
- Strap subject  / place hand on platform / connect BP, etc   ______________ 
- Record distance between THRIM leads  
-           Chest (LThorax)  __________ cm 
-            Abdomen  _______________cm 
-            UL _____________________cm 
-            LL ______________________cm 
             
Measurement/Data Acquisition Phase: 
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- confirm working condition of all devices (PC, BP, WindaQ signals, ECg signals) ____ 
- place subject according to matrix (HUT=0 or HUT=80 with or without SHORTS) ____ 
- ask subject to sit still / no talk for 1 min      _______________________ 
- take manual BP / HR  and record on data sheet.         _______________ 
- Take 3 min of continuous BP + Impedance measurements   ____________ 
- Tilt table (up / down),  
- ask subject to sit still / no talk for 1 min      _______________________ 
- take manual BP / HR  and record on data sheet.         _______________ 
- Take 3 min of continuous BP + Impedance measurements   ____________ 
- Allow subject to get off HUT table and remove/put on SHORTS  _________ 
- Re-connect Impedance/ ECG Leads   __________________ 
- Repeat above CV data Acquisition (1+3 +1+3 min)  
                    for another NO SHORTS/ SHORTS condition    __________________ 
 
De-instrumentation Phase 
- Remove Straps   ______________________ 
- Remove BP cuff  / finger/ hand   __________________ 
- Remove Leads / Electrodes   ____________________ 
- Allow subject to stand up / remove shorts   _________________ 
- Check subject feeling good / Release subject   ________________ 
- Disinfect shorts  ____________________ 
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Appendix C 
 
 
Informed Consent (IRB form C) 
 
 
Consent to Participate in a Research Study 
EFFECT OF LOWER BODY POSITIVE PRESSURE ON CARDIOVASCULAR RESPONSE 
AT VARIOUS DEGREES OF HEAD UP TILT 
WHY ARE YOU BEING INVITED TO TAKE PART IN THIS RESEARCH? 
You are being invited to take part in a research study about the effects of lower body positive 
pressure on cardiovascular response at rest and at various degrees of head up tilt. You are being 
invited to take part in this research study because you are a healthy person between the ages of 18 
and 45.   If you volunteer to take part in this study, you will be one of about 40 people to do so.  
 
WHO IS DOING THE STUDY?  
The person in charge of this study is Vladimir Kostas, a graduate student at the University of 
Kentucky Department of Kinesiology and Health Promotion. He is being guided in this research by J. 
W. Yates, PhD.  There may be other people on the research team assisting at different times during 
the study. 
 
WHAT IS THE PURPOSE OF THIS STUDY? 
By doing this study, we hope to learn how the body responds to fluid shifts from lower 
extremities towards the chest area, a condition which might be experienced by an astronaut while in 
zero-gravity in space or while in an anti-gravity suit upon return to Earth, as well as fluid shift towards 
the lower extremities when no compression garment is present. 
 
ARE THERE REASONS WHY YOU SHOULD NOT TAKE PART IN THIS STUDY? 
If you are under 18 or over 45 years of age, are prone to fainting, are pregnant, had major 
surgery in the past year, your doctor has restricted you from activity, your blood pressure is greater 
that 140/90 or you have a diagnosis of HIV/AIDS, you should not participate in this study.  
WHERE IS THE STUDY GOING TO TAKE PLACE AND HOW LONG WILL IT LAST?  
The research procedures will be conducted at the Biodynamics Laboratory in the Center for 
Biomedical Engineering on the University of Kentucky campus.  You will need to come to the 
Biodynamics Laboratory one time during the study.  The visit will take about 1.5 hrs.   
WHAT WILL YOU BE ASKED TO DO? 
     You will be asked to review this document and provide informed consent to continue as a 
subject in the study. If you agree to participate, you will be asked to fill out a short questionnaire to 
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help the investigators determine if you can participate.  If you are prone to fainting, have experienced 
dizziness or lightheadedness getting out of bed or standing up from a chair in the past, you will be 
excused. 
Next, one of the investigators will take your resting blood pressure. If your pressure is less 
than 140/90 mmHg, you can continue. At this point your weight, height and waist circumference will 
be measured. Then you will be asked to try on several pairs of shorts to determine the ones that fit 
best. You will also get familiarized with the tilt table operation.  
In addition to wearing shorts, you will also wear a blood pressure cuff on one of the arms and 
also on one finger and 12 electrodes placed on various body parts (chest, leg, arm, neck).  
During the whole study you will be asked to stay quiet and still four times for 3 minutes at a 
time at various phases of the study with or without the shorts on while your body is tilted on the table 
to various positions. Your body will be strapped to the table while you are tilted to prevent you from 
shifting forward or sideways too much.  
Several measurements will be taken while you are lying down on the table or tilted into 
standing position. You will not feel anything during these measurements, except the blood pressure 
cuff on your arm and finger inflating.  If you feel lightheaded or dizzy anytime during the study or 
experience any other sign of discomfort, you should tell the attending personnel immediately. 
After data collection is complete, you will be helped in removing the electrodes from your 
skin. Then you will be allowed to leave the tilt table and remove the shorts in the dressing room, after 
which you will be excused. 
 
WHAT ARE THE POSSIBLE RISKS AND DISCOMFORTS? 
This is a minimal level of activity and represents a minimal risk to healthy subjects. Potential 
Risks could occur from the Tilt Test, Electrode Placement, Alter-G shorts and Electrical 
Instrumentation. 
 
Tilt Test 
 
A.  Potential Hazard Cause: There is some risk of feeling lightheaded or fainting with 
upright tilt. 
B.  Effects of the Hazard: Patient could become presyncopal or syncopal. 
C.  Assessment-Severity & Probability: Reasonable/Medium 
D.         Protection to Minimize Risks: If the subject feels lightheaded, blood pressure or heart 
rate begins to fall (see below) or faints while standing, the tilt table will be returned to a supine or 
head-down position and the test will be terminated. Subject restraints will be used during the tilt test 
to keep the subject from falling. The tilt test will be terminated if any of the following instances occur 
while the subject is tilted upright: 
 
1. A sudden drop in heart rate greater than 15 beats per minute 
2. A sudden drop in blood pressure (systolic fall > 25 mmHg or diastolic fall > 15 
mmHg in one minute) 
3. Significant cardiac arrhythmias 
4. Heart rate < 40 beats per minute for people whose resting heart rate is > 50 beats per 
minute 
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5. Tachyarrhythmias (three or more beats in a row of supraventricular or ventricular 
tachycardia) 
6. Evidence of heart block other than first degree 
7. Premature ventricular contractions (PVC) which meet the following criteria: 
6 or more PVC's/minute 
PVC's that are closely coupled 
PVC's that fall on the T wave of the preceding beat 
PVC's which are multiformed 
PVC’s in couplets or runs (ventricular tachycardia) 
8. An absolute systolic blood pressure of 70 mmHg or less 
9. Severe nausea 
10. Clammy skin 
11. Profuse sweating 
12. Pallor 
13. Light-headedness 
14. Dizziness or tingling 
15. Sudden chest tightness or difficulty breathing 
16. Subject request at any time 
17. Prolonged loss of ECG signal 
Electrodes 
 
      A. Potential Hazard Cause: Allergic reaction or skin irritation due to electrode application 
process 
      B. Effects of the Hazard: Subject discomfort due to skin irritation 
      C. Assessment-Severity & Probability: Marginal/Low 
       D. Protection to minimize risks: Only standard, medically approved, electrodes are used. 
Electrodes will not be worn more than 1hr at a time. 
Alter-G Shorts 
There is small risk of infection when the “Alter-G” garment is worn. As this study will enroll 
only healthy subjects, the risk is considered extremely small. To reduce the risk further, each subject 
will be provided with a clean pair of “Alter-G” garments, after they have been washed in an anti-
microbial and bleach solution. 
Electrical Instrumentation 
 
A. Potential Hazard Cause:  Improperly grounded instrumentation, or failure of 
electrical protection circuitry 
B. Effects of the Hazard:  Subject injury due to electrical shock 
C. Assessment-Severity & Probability:  Critical/Extremely low 
D. Protection to Minimize Risks:   
1. Grounding will be confirmed through scheduled preventative maintenance. 
2. All cables will be insulated and properly strain-relieved to avoid breakage during 
voluntary movements. 
3. Physiological amplifiers for monitoring will limit electrode current, even under fault 
conditions, to less than 50 µamps for all electrode leads combined, which is within the guidelines 
established by Human Research Policy and Procedures. 
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In addition to the risks and discomforts listed above, you may experience a previously 
unknown risk or side effect. 
 
WILL YOU BENEFIT FROM TAKING PART IN THIS STUDY? 
You will receive information regarding your heart rate, blood pressure, stroke volume and 
cardiac output response measured during rest. In addition, your willingness to take part may help 
better understand this research topic. 
 
DO YOU HAVE TO TAKE PART IN THE STUDY? 
If you decide to take part in the study, it should be because you really want to volunteer.  You 
will not lose any benefits or rights you would normally have if you choose not to volunteer.  You can 
stop at any time during the study and still keep the benefits and rights you had before volunteering.   
IF YOU DON’T WANT TO TAKE PART IN THE STUDY, ARE THERE OTHER CHOICES? 
If you do not want to be in the study, there are no other choices except not to take part in the 
study. 
 
WHAT WILL IT COST YOU TO PARTICIPATE? 
You may have to pay for the cost of getting to the study site and a parking fee. 
 
WILL YOU RECEIVE ANY REWARDS FOR TAKING PART IN THIS STUDY? 
You will receive monetary compensation for taking part in the study . When you arrive for the 
study, you will receive $10. Then, if you are admitted to participate in the study (i.e. if you meet the 
qualification criteria for the study ) you will receive and additional $15 at the end of the study for a 
total of $25. 
 
WHO WILL SEE THE INFORMATION THAT YOU GIVE? 
We will make every effort to keep private all research records that identify you to the extent 
allowed by law. 
Your information will be combined with information from other people taking part in the study. 
When we write about the study to share it with other researchers, we will write about the combined 
information we have gathered. You will not be personally identified in these written materials. We may 
publish the results of this study; however, we will keep your name and other identifying information 
private.  
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This study is confidential. That means that only study personnel will know who participates 
We may be required to show information, which identifies you to people who need to be sure we have 
done the research correctly; these would be people from such organizations as the University of 
Kentucky. 
 
 
CAN YOUR TAKING PART IN THE STUDY END EARLY? 
If you decide to take part in the study you still have the right to decide at any time that you no 
longer want to continue.  You will not be treated differently if you decide to stop taking part in the 
study.   
The individuals conducting the study may need to withdraw you from the study.  This may 
occur if you are not able to follow the directions they give you, if they find that your being in the study 
is more risk than benefit to you, or if the agency funding the study decides to stop the study early for a 
variety of scientific reasons.  
 
If you only partially complete the study, you will be monetarily compensated in the amount of 
$25. 
 
 
WHAT HAPPENS IF YOU GET HURT OR SICK DURING THE STUDY? 
 
If you believe you are hurt or if you get sick because of something that is due to the study, 
you should call Vladimir Kostas at (502) 407-7916 or Dr. J.W. Yates at 859-257-5879 immediately. 
They will determine what type of treatment, if any, that is best for you at that time. 
It is important for you to understand that the University of Kentucky does not have funds set 
aside to pay for the cost of any care or treatment that might be necessary because you get hurt or 
sick while taking part in this study. Also, the University of Kentucky will not pay for any wages you 
may lose if you are harmed by this study.  
Medical costs that result from research related harm can not be included as regular medical 
costs.  Therefore, the medical costs related to your care and treatment because of research related 
harm will be your responsibility. 
You do not give up your legal rights by signing this form. 
 
WHAT IF YOU HAVE QUESTIONS, SUGGESTIONS, CONCERNS, OR COMPLAINTS? 
 
Before you decide whether to accept this invitation to take part in the study, please ask any 
questions that might come to mind now.  Later, if you have questions, suggestions, concerns, or 
complaints about the study, you can contact the investigator, Vladimir Kostas at (859) 227-2074 / 
vlad.kostas@uky.edu or his advisor, Dr. J.W. Yates at 859-257-5879.   If you have any questions 
about your rights as a volunteer in this research, contact the staff in the Office of Research Integrity at 
the University of Kentucky at 859-257-9428 or toll free at 1-866-400-9428.  We will give you a signed 
copy of this consent form to take with you.  
 
WHAT ELSE DO YOU NEED TO KNOW? 
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At this time, there is no additional info that you, as a subject, need to know, while participating 
in this study. 
 
_________________________________________   ____________ 
Signature of person agreeing to take part in the study          Date 
  
_________________________________________ 
Printed name of person agreeing to take part in the study 
  
____________________________________   ____________ 
Name of [authorized] person obtaining informed consent                     Date  
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Appendix D 
 
 
Medical History Form 
 
 
 
Medical History 
 
                  Name (First, Last) ________________________________ 
 
                  Birth Date _______________________________________ 
 
 
Personal: 
 
Y       N       
___   ___   Have you ever been diagnosed as having heart disease? 
                  Yes, ______________________________________ 
___   ___   Have you ever had any other significant medical conditions? 
                  Yes, ______________________________________ 
___   ___   Have you had a major surgery in the past year? 
                  Yes, ______________________________________ 
___   ___   Do you smoke? 
                  Yes, ______________________________________ 
___   ___   Are you currently using any prescription medication 
                  Yes, ______________________________________ 
___   ___   Are you prone to fainting/dizziness / have you fainted in the past? 
                  Yes, ______________________________________ 
___   ___   Are you pregnant? (F) 
                  Yes, ______________________________________ 
___   ___   Have you been diagnosed with HIV/AIDS ? 
                  Yes, ______________________________________ 
 
Family: 
 
Y       N       
___   ___   Has a member of your family ever been diagnosed with heart 
disease? 
                  Yes, ______________________________________ 
___   ___   Has anyone in your family ever died from heart attack or cardiac 
event? 
                  Yes, ______________________________________ 
___   ___   Has anyone in your family died suddenly before 50 years of age? 
                  Yes, ______________________________________ 
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Appendix E 
 
 
Par-Q form 
 
 
 
Regular physical activity is fun and healthy, and increasingly more people are starting to become more 
active every day. 
Being more active is very safe for most people. However, some people should check with their 
physician before they 
start becoming more physically active. Please complete this form as accurately and 
completely as possible. 
 
PAR-Q FORM Please mark YES or No to the following: YES NO 
Has your doctor ever said that you have a heart condition and recommended 
only medically supervised physical activity? ____ ____ 
Do you frequently have pains in your chest when you perform physical activity? ____ ____ 
Have you had chest pain when you were not doing physical activity? ____ ____ 
Have you had a stroke? ____ ____ 
Do you lose your balance due to dizziness or do you ever lose consciousness? ____ ____ 
Do you have a bone, joint or any other health problem that causes you pain or 
limitations that must be addressed when developing an exercise program 
(i.e. diabetes, osteoporosis, high blood pressure, high cholesterol, arthritis, 
anorexia, bulimia, anemia, epilepsy, respiratory ailments, back problems, etc.)? ____ ____ 
Are you pregnant now or have given birth within the last 6 months? ____ ____ 
Do you have asthma or exercise induced asthma? ____ ____ 
Do you have low blood sugar levels (hypoglycemia)? ____ ____ 
Do you have diabetes? ____ ____ 
Have you had a recent surgery? ____ ____ 
If you have marked YES to any of the above, please elaborate below: 
__________________________________________________________________________ 
__________________________________________________________________________ 
__________________________________________________________________________ 
Do you take any medications, either prescription or non-prescription, on a regular basis? 
Yes/No 
What is the medication for? 
How does this medication affect your ability to exercise or achieve your fitness goals? 
_________________________________________________________________________ 
_________________________________________________________________________ 
________________________________________________ 
Please note: If your health changes such that you could then answer YES to any of the 
above 
questions, tell your trainer/coach. Ask whether you should change your physical activity 
plan. 
I have read, understood, and completed the questionnaire. Any questions I had were 
answered to my 
full satisfaction. 
Print Name: _________________________________Signature: 
__________________________________ 
Date: _______________________________________ 
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Appendix F 
 
 
Raw Data (subject data acquisition phase) 
 
 
 
 
Table F.1. Raw cardiovascular data 
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Raw Data (subject data acquisition phase), continued 
 
 
 
 
58 
 
Appendix G 
 
 
Subject and Impedance Data 
 
 
 
 
 
 
  Table G.1. Subject demographic and impedance data 
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Appendix H 
 
 
Resulting Cardiovascular Values and T-test Results 
 
 
 
 
 
 
Table H.1. Resulting cardiovascular values and t-test results. 
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